FRIEDL-NADERER JOHANNA (Chief Commercial Officer) sold 0.1% of their position (145.00 shares) of DYNE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/17/2026ACC: 0001915598-26-000002
Officer· Chief Commercial Officer
Since Mar 2026
-145.00
Net shares
Net seller
$2.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
145.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−145.00
Price / share
$18.33
Trade value
$2.66K
% of position
0.1%
6/16/2026
154.35K→154.21K
Total
Net shares
−145.00
Net value
-$2.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/16/2026 | S · Sale | −145.00 | $18.33 | $2.66K | 0.1% | 154.35K | 154.21K |
| Total | −145.00 | -$2.66K | ||||||
Derivative Transactions0
No derivative transactions reported